Month: October 2014

BioTime Cell Cure Files IND with FDA for ES cell AMD therapy

Cell-Cure-Logo

Stem cell biotech BioTime announced the news today that its subsidiary Cell Cure Neurosciences (Cell Cure) has filed an IND with the FDA for an embryonic stem (ES) cell-based therapy for Dry age-related macular degeneration (AMD). The product to be tested is OpRegen, which the company indicates is “the first IND for an ES cell-based …

BioTime Cell Cure Files IND with FDA for ES cell AMD therapy Read More »

Self-plagiarism polling: Is it OK, misconduct, or depends?

Potential self-plagiarism is a hot button issue right now in scientific publishing. Is it ever OK to reuse your own published data or words? Should it be considered misconduct if you don’t acknowledge it? If you acknowledge re-use of your own words or data/images is that re-use still a problem? Or should we not even …

Self-plagiarism polling: Is it OK, misconduct, or depends? Read More »

Home stretch on October deadline NIH grant & I’m…(fill in the blank)

Grant deadlines are no picnic. Like thousands of scientists around the US, I too am working on a big NIH grant proposal due in a matter of a few days. If you are also in this boat, how are you all feeling right now since it is October 1st? How would you complete this sentence: “I need to …

Home stretch on October deadline NIH grant & I’m…(fill in the blank) Read More »